Literature DB >> 25036795

Indolinone-based acetylcholinesterase inhibitors: synthesis, biological activity and molecular modeling.

Hamidreza Akrami1, Bibi Fatemeh Mirjalili1, Mehdi Khoobi2, Hamid Nadri3, Alireza Moradi3, Amirhossein Sakhteman3, Saeed Emami4, Alireza Foroumadi2, Abbas Shafiee5.   

Abstract

A series of indolinone-based compounds bearing benzylpyridinium moiety was designed as dual-binding inhibitors of acetylcholinesterase (AChE). The target compounds 3a-u were synthesized by condensation of oxindole and pyridin-4-carbalehyde, and subsequent N-benzylation. The anti-cholinesterase activity evaluation of synthesized compounds revealed that most of them had very potent inhibitory activity against AChE, superior to standard drug donepezil. Particularly, 2-chlorobenzyl derivative 3c was the most potent compound against AChE with IC50 value of 0.44 nM, being 32-fold more potent than donepezil. Also, most of compounds were more potent than standard drug donepezil against butyrylcholinesterase (BuChE). Docking study revealed that the hydrophobic aromatic part (indoline) of representative compound 3c binds to the PAS and the N-benzylpyridinium residue binds to the CAS of AChE.
Copyright © 2014 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Acetylcholinesterase; Alzheimer's disease; Docking study; Indolinone; Oxindole

Mesh:

Substances:

Year:  2014        PMID: 25036795     DOI: 10.1016/j.ejmech.2014.01.017

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  6 in total

1.  The Prophylactic and Multimodal Activity of Two Isatin Thiosemicarbazones against Alzheimer's Disease In Vitro.

Authors:  Barbara Mavroidi; Archontia Kaminari; Dimitris Matiadis; Dimitra Hadjipavlou-Litina; Maria Pelecanou; Athina Tzinia; Marina Sagnou
Journal:  Brain Sci       Date:  2022-06-19

Review 2.  Chalcone and its analogs: Therapeutic and diagnostic applications in Alzheimer's disease.

Authors:  Pritam Thapa; Sunil P Upadhyay; William Z Suo; Vikas Singh; Prajwal Gurung; Eung Seok Lee; Ram Sharma; Mukut Sharma
Journal:  Bioorg Chem       Date:  2021-01-29       Impact factor: 5.307

Review 3.  Profiling donepezil template into multipotent hybrids with antioxidant properties.

Authors:  Eva Mezeiova; Katarina Spilovska; Eugenie Nepovimova; Lukas Gorecki; Ondrej Soukup; Rafael Dolezal; David Malinak; Jana Janockova; Daniel Jun; Kamil Kuca; Jan Korabecny
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

4.  Design, synthesis, biological evaluation and molecular docking study of novel pyridoxine-triazoles as anti-Alzheimer's agents.

Authors:  Tiyas Pal; Saipriyanka Bhimaneni; Abha Sharma; S J S Flora
Journal:  RSC Adv       Date:  2020-07-09       Impact factor: 4.036

Review 5.  Recent developments in the design and synthesis of benzylpyridinium salts: Mimicking donepezil hydrochloride in the treatment of Alzheimer's disease.

Authors:  Saghi Sepehri; Mina Saeedi; Bagher Larijani; Mohammad Mahdavi
Journal:  Front Chem       Date:  2022-09-26       Impact factor: 5.545

6.  Metformin and its sulphonamide derivative simultaneously potentiateanti-cholinesterase activity of donepezil and inhibit beta-amyloid aggregation.

Authors:  Magdalena Markowicz-Piasecka; Kristiina M Huttunen; Joanna Sikora
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.